✦ LIBER ✦

Tumor Necrosis Factor–α as a Treatment Target for the Cancer Anorexia/Weight Loss Syndrome

✍ Scribed by Jatoi, Aminah; Sideras, Kostandinos; Nguyen, Phuong L.

Book ID: 122586056
Publisher: CIG Media Group, LP.
Year: 2004
Tongue: English
Weight: 111 KB
Volume: 1
Category: Article
ISSN: 1543-2912
DOI: 10.3816/SCT.2004.n.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor necrosis factor-α blocking agent a

Tumor necrosis factor-α blocking agent as a treatment for nephrotic syndrome

✍ David Raveh; Ovadia Shemesh; Yaakov Jack Ashkenazi; Robert Winkler; Vivian Barak 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 191 KB

P062 Identification of the XAF1 tumor su

P062 Identification of the XAF1 tumor suppressor as a transcription target of tumor necrosis factor-α-NF-κB signaling in human colon cancer cells

✍ Kim, J.-W.; Lee, C.-K.; Kim, H.J. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 69 KB

A placebo-controlled double blind trial

A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome : Results from N00C1 from the North Central Cancer Treatment Group

✍ Aminah Jatoi; Shaker R. Dakhil; Phuong L. Nguyen; Jeff A. Sloan; John W. Kugler; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract ## BACKGROUND. Tumor necrosis factor‐α (TNF‐α) is a putative mediator of the cancer anorexia/weight loss syndrome. The current study was designed to determine whether etanercept (a dimeric fusion protein consisting of the extracellular ligand‐binding portion of the human 75‐kilodalton